Mangalam Drugs' shares surged 5% to the upper circuit after ace investor Vijay Kedia’s firm bought a stake worth over Rs 33 lakh.
Investor’s purchase details
On December 29, Kedia Securities Private Limited purchased about 1.38 lakh shares of Mangalam Drugs at Rs 24.15 each. The total cost was roughly Rs 33.28 lakh, which is about 3% lower than the previous closing price of Rs 24.96.
What the company does
Mangalam Drugs and Organics manufactures active pharmaceutical ingredients (APIs) and chemical intermediates used in the pharma industry.
Recent stock movement
- The stock has risen almost 10% over the last five trading days.
- It fell about 68% in the past six months.
- Year‑to‑date, the share price is down more than 78%.
- After reaching a 52‑week high of Rs 124.89 on Jan 1, it dropped to a 52‑week low of Rs 22.80 yesterday.
- Current market capitalisation is roughly Rs 42 crore.
Remember, this is perspective, not a prediction. Do your own research before making any investment decisions.